Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin ...
There have been postmarketing reports of hypersensitivity in patients shortly after initiation of treatment with LYRICA. Adverse ... There were reports of life-threatening angioedema with respiratory compromise requiring emergency treatment ...
MarketWatch - Thu, 18 Dec 2014 04:56

Leukotrienes induce the migration of Th17 cells
... IL-17A, is necessary for many types of immune response.3, 4, 5 IL-17A knockout mice show weaker contact hypersensitivity, delayed-type hypersensitivity and airway hypersensitivity responses than control mice.25 IL-17A secretion by Th17 cells could ...
Nature.com - Tue, 16 Dec 2014 03:06

CUHK Unveils Genome of Dermatophagoides farinae
Allergy, a hypersensitivity disorder of the immune system triggered by normally harmless substances in the environment, is usually developed during childhood. Respiratory allergies are incurable, and have become one of the major public health issues ...
HealthCanal.com - Tue, 16 Dec 2014 02:30

BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Brazil for Treatment of ...
If severe hypersensitivity reactions occur, immediately stop the infusion of VIMIZIM and initiate appropriate treatment. Patients with acute febrile or respiratory illness at the time of VIMIZIM infusion may be at higher risk of life-threatening ...
NewsOK.com - Wed, 10 Dec 2014 04:56

BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Australia for Treatment of ...
If severe hypersensitivity reactions occur, immediately stop the infusion of VIMIZIM and initiate appropriate treatment. Patients with acute febrile or respiratory illness at the time of VIMIZIM infusion may be at higher risk of life-threatening ...
CNNMoney - Sun, 07 Dec 2014 13:00

Substance evaluation – understanding the process
In this respect, it should be noted that, at present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available, although criteria for classification and labelling (C&L) are. Contrary to this, several ...
Chemical Watch (subscription) - Thu, 20 Nov 2014 04:06



FDA Approves Hysingla ER – Extended-Release Hydrocodone with Abuse ...
... respiratory depression, acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment, known or suspected paralytic ileus and gastrointestinal obstruction, and hypersensitivity to any component of Hysingla ...
ProHealth - Sat, 29 Nov 2014 22:22

Results of Long-Term, Open-Label Study Published in the Journal of Pain ...
Zohydro ER is contraindicated in patients with: significant respiratory depression; acute or severe bronchial asthma; known or suspected paralytic ileus; and hypersensitivity to hydrocodone bitartrate. Zohydro ER warnings for: interactions with CNS ...
CNNMoney - Mon, 01 Dec 2014 05:30


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014